For the Inventor, By the Inventor

Enter assignee name

Plymouth Meeting, PA, United States of America

Magainin Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 34

Forward Citations = 777

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Michael A Zasloff (17 out of 56 patents)

William Alvin Kinney (11 out of 65 patents)

U Prasad Kari (7 out of 9 patents)

4. W Lee Maloy (6 out of 18 patents)

5. Ann Shinnar (6 out of 7 patents)

6. Steven Jones (5 out of 6 patents)

7. Meena N Rao (5 out of 6 patents)

8. Jon I Williams (4 out of 15 patents)

9. Barry S Schonwetter (3 out of 3 patents)

10. Leah L Frye (3 out of 3 patents)

11. Robert Moriarty (3 out of 3 patents)

12. Michael McLane (2 out of 12 patents)

13. Harold Meckler (2 out of 25 patents)

14. Nicholas C Nicolaides (2 out of 88 patents)

15. Roy Clifford Levitt (2 out of 23 patents)

Core Competencies:

Aminosterol Compounds

Biologically Active Peptides

Squalamine

Viral Infection Treatment

Antimicrobial Peptides

Angiogenesis Inhibition

Asthma Treatment

Gynecological Malignancies

Steroid Derivatives

Defensin Peptides

Peptide Compositions

Pharmaceutical Compositions

34 patents: Sort by Forward Citations

1. 6610866 - Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds (2003-08-26),

2. 6348445 - Biologically active peptides with reduced toxicity in animals and a method for preparing same (2002-02-19),

3. 6262283 - Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds (2001-07-17),

4. 6147060 - Treatment of carcinomas using squalamine in combination with other (2000-11-14),

5. 6143738 - Therapeutic uses for an aminosterol compound (2000-11-07),

6. 6037149 - DNA encoding human asthma associated factor 1 (2000-03-14),

7. 5994336 - Method of inhibiting proliferation of cells by administering an (1999-11-30),

8. 5908839 - Asthma associated factors as targets for treating atopic allergies (1999-06-01),

9. 5874597 - Certain aminosterol compounds and pharmaceutical compositions including (1999-02-23),

10. 5856535 - Aminosterol ester compounds (1999-01-05),

11. 5849490 - Inducible defensin peptide from mammalian epithelia (1998-12-15),

12. 5847172 - Certain aminosterol compounds and pharmaceutical compositions including (1998-12-08),

13. 5840936 - Aminosterol compounds useful as inhibitors of the sodium/proton (1998-11-24),

14. 5840740 - Aminosterol compounds and a method of treating infection using the (1998-11-24),

15. 5795885 - Method of inhibiting profileration of cells by administering an (1998-08-18),

Company Overview

Magainin Pharmaceuticals, Inc. is a biotechnology company based in Plymouth Meeting, PA, specializing in the development of innovative therapeutics. The company focuses on advancing peptide-based technologies for the treatment of various medical conditions, particularly in the fields of infectious diseases and dermatology. With a commitment to research and development, Magainin aims to harness the potential of its proprietary platforms to create effective solutions that address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

34 Patents

#4 in Plymouth Meeting, PA

#367 in Pennsylvania

#10,028 in US

#19,664 in the World

Plymouth Meeting, PA, United States of America

Magainin Pharmaceuticals, Inc.

Forward Citations = 777

28 inventors:

Michael A Zasloff (17 out of 56 patents)

William Alvin Kinney (11 out of 65 patents)

U Prasad Kari (7 out of 9 patents)

4. W Lee Maloy (6 out of 18 patents)

5. Ann Shinnar (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Magainin Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/magainin-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…